Ioana Hone
Head of Investor Relations
Replay available
Lineage Cell Therapeutics, Inc. (AMEX: LCTX) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chief Executive Officer
Chief Financial Officer
Senior Vice President and Head of Clinical
Analyst, B. Riley Securities
Analyst, Canaccord and Genovese
Analyst, H.E. Wainwright
Watch the replay and follow the connected company analysis, news, and investor updates for Lineage Cell Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.112 Welcome to the Lineage Cell Therapeutics Second Quarter 2026 Conference Call. 00:00:05.112 -- 00:00:08.433 At this time, all participants are in listen-only mode. 00:00:08.433 -- 00:00:14.035 An audio webcast of this call is available on the Investors section of Lineage's website 00:00:14.035 -- 00:00:16.935 at www.lineagecell.com. 00:00:18.436 -- 00:00:23.618 This call is subject to the copyright and is the property of Lineage and Recordings. 00:00:23.618 -- 00:00:30.382 Reproductions or transmissions of this call without the express written consent 00:00:30.382 -- 00:00:35.665 of Lineage are strictly prohibited. As a reminder, today's call is being recorded. 00:00:35.665 -- 00:00:40.387 I would now like to introduce your host for today's call, Ioana Hone, Head of Investor 00:00:40.387 -- 00:00:44.469 Relations at Lineage. Ms. Hone, please go ahead. 00:00:44.469 -- 00:00:47.831 Thank you, Jericho. Good afternoon, and thank you for joining us. 00:00:47.831 -- 00:00:53.014 A press release reporting our second quarter 2026 financial results was issued 00:00:53.014 -- 00:00:58.057 earlier today, August 6, 2026, and can be found on the investor section of 00:00:58.057 -- 00:01:03.482 our website. Please note that today's remarks and responses to your questions reflect 00:01:03.482 -- 00:01:08.165 management's views as of today only and will contain forward-looking statements within 00:01:08.165 -- 00:01:12.968 the meaning of federal securities laws. Statements made during this discussion that are 00:01:12.968 -- 00:01:17.871 not statements of historical fact should be considered forward-looking statements which 00:01:17.871 -- 00:01:21.013 are subject to significant risks and uncertainties. 00:01:21.013 -- 00:01:26.636 The company's ac...